The rate of lariat formation is decreased two-fold by isoginkgetin treatment. by Jesse M. Gray (527662)

“…The height of each bar indicates the fold change, from vehicle- to isoginkgetin-treated cells, in the mean fraction of reads aligning to each genic feature (<i>p</i><0.02 from two-tailed <i>t</i>-tests for all ratios). …”

Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups. by Kazuhiko Ikeuchi (9234268)

Subjects:

Regions of significantly decreased ACM of SP-MS relative to RR-MS patients. by Mark Lyksborg (583318)

Identification of proteins that presented a significant decrease in their expression content. by Rubens D. M. Magalhães (395962)

SLE decreases risk for hormonal cancers. by Deborah K. Johnson (10001156)

“…(b) Prostate cancer incidence in male SLE cohort is significantly decreased by SLE status (OR 0.23, 95% CI 0.089, 0.50, p = 0.0053).…”

Comparison of the ISIs that caused 0%, 50% and 100% decreases in response magnitudes (AI spikes, AI fEPSP and MGBv spikes) to succeeding tone. by Colin Xiong (9182695)

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…<p>Resveratrol treatment decreases PKM2 mRNA in (A), HeLa; (B), HepG2 and (C), MCF-7; by approximately two-folds. β-actin was taken as endogenous control and normalized to PKM2 mRNA. …”

An increase in MOI decreases neuronal dendrite numbers. by Emily Z. Tabaie (16630841)

Rg3 decreases HDAC3 expression. by Xiu Shan (62157)

* months from treatment initiation. by Kazuhiko Ikeuchi (9234268)

Subjects:

Association between the slope of the ratio of the post-treatment RPR titer compared to the baseline titer and other characteristics using linear regression analysis. by Kazuhiko Ikeuchi (9234268)

Subjects:

Temporal changes in the RPR titer from before to after treatment. by Kazuhiko Ikeuchi (9234268)

Subjects:

Flow chart of the study procedures. by Kazuhiko Ikeuchi (9234268)

Subjects:

PNs, ORNs and LNs response to a short (50 ms) pulse, similar results of Fig 4. by Mario Pannunzi (553941)

RDV and EIDD2801 EC₅₀ and fold-change in VeroE6-ACE2-TMPRSS2. by Agnieszka M. Szemiel (10196243)

Clustering of metastable states using the first 50 ns of post-translational folding trajectories of CAT-III with ligand bound. by Yang Jiang (46459)

Subjects:

DART-ID decreases missing datapoints across runs. by Albert Tian Chen (6900215)

“…Only peptides seen in >50% of experiments are included. (<b>b</b>) Decrease in missing data across all runs after applying DART-ID, for SCoPE-MS and the two bulk sets from <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007082#pcbi.1007082.g004" target="_blank">Fig 4</a> at 1% FDR. …”

The decrease in hBMVEC death is associated with reduced activation of Caspase-3. by Simona F. Spampinato (773594)

Comparison of the performance of the 10 CV (10 fold cross validation) model and the permutated model. by Sakuni Rankothgedera (11457923)

Subjects:

ETHE1-p.Arg163Gln and p.Arg163Trp are folded but have decreased stability. by Bárbara J. Henriques (627180)